Interpretation of the association between beta-blockers and hip/femur fracture.
Frank
F
de Vries
Patrick
P
Souverein
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000818:Animals; D001847:Bone Diseases / Q000209:etiology* / Q000517:prevention & control*; D002227:Carbazoles / Q000627:therapeutic use*; D048909:Diabetes Complications / Q000209:etiology* / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D008297:Male; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines